Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer

International Journal of Gynecological Cancer

Volumn 20, Issue 2, 2010, Pages 233-239

  Michelsen, Trond Melbye ^a,b,c   Tonstad, Serena ^d   Pripp, Are H ^b   Tropé, Claes G ^b,c   Dørum, Anne ^b,c  

^a Section for Gastroenterology   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d Department of Preventive Cardiology ^*  (Japan)

Author keywords

BRCA1; BRCA2; Coronary heart disease; Framingham risk score; Risk factors; Salpingo oophorectomy

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANAMNESIS; ARTICLE; BODY MASS; BREAST CANCER; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENETIC COUNSELING; HELP SEEKING BEHAVIOR; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; NORWAY; OVARY CANCER; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK REDUCTION; SALPINGOOOPHORECTOMY; SCORING SYSTEM; SURVIVAL; SYSTOLIC BLOOD PRESSURE; UNEMPLOYMENT; WAIST CIRCUMFERENCE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; MIDDLE AGED; OVARIECTOMY; OVARY TUMOR; UTERINE TUBE;

ADULT; CASE-CONTROL STUDIES; CORONARY DISEASE; FALLOPIAN TUBES; FEMALE; HUMANS; MIDDLE AGED; NORWAY; OVARIAN NEOPLASMS; OVARIECTOMY; RISK ASSESSMENT;

EID: 77951892457     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181ca5ff4     Document Type: Article

References (20)

1. Rebbeck TR, Kauff ND, Domchek SM. Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers. J Natl Cancer Inst. 2009;101:80-87.
2. Atsma F, Bartelink ML, Grobbee DE, et al. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265-279.
3. Rocca WA, Grossardt BR, de Andrade A, et al. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006;7:821-828.
4. Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause. 2009;16:15-23.
5. Hsia J, Barad D, Margolis K, et al. Usefulness of prior hysterectomy as an independent predictor of Framingham risk score (the Women's Health Initiative). Am J Cardiol. 2003;92:264-269.
6. Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105-1110.
7. Lobo RA. Surgical menopause and cardiovascular risks. Menopause. 2007;14:562-566.
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
9. Dørum A, Tonstad S, Liavaag AH, et al. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecol Oncol. 2008;109:377-383.
10. Michelsen TM, Pripp AH, Tonstad S, et al. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer. 2009;45:82-89.
11. Holmen J, Midthjell K, Krüger Ø, et al. The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods and participation. Norsk Epidemiologi. 2003;13:19-32.
12. Thorsen L, Nystad W, Stigum H, et al. The association between self-reported physical activity and prevalence of depression and anxiety disorder in long-term survivors of testicular cancer and men in a general population sample. Support Care Cancer. 2005;13:637-646.
13. American Heart Association. Risk factors and coronary heart disease. American Heart Association; 2009. Available at: http://www.americanheart.org/ presenter.jhtml?identifier=4726. Accessed January 9, 2009.
14. Løkkegaard E, Jovanovic Z, Heitmann BL, et al. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas. 2006;53:226-233.
15. Tunstall-Pedoe H, Woodward M; SIGN group on risk estimation. By neglecting deprivation, cardiovascular risk scoring will exacerbate social gradients in disease. Heart. 2006;92:307-310.
16. Hense HW, Schulte H, Lö wel H, et al. Framingham risk function overestimates risk of coronary heart disease in men and women from GermanyVresults from the MONICA Augsburg and the PROCAM cohorts. Eur Heart J. 2003;24:937-945.
17. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet. 2005;366:1059-1062.
18. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
19. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465-1477.
20. Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996;275:1885-1892.